title: Stakeholders discuss biosimilar naming, substitution.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000145:classification* / Q000592:standards* / Q000627:therapeutic use; D017277:Drug Approval / Q000379:methods; D057915:Drug Substitution / Q000379:methods / Q000592:standards*; D006801:Humans; D014481:United States; D014485:United States Federal Trade Commission / Q000331:legislation & jurisprudence / Q000592:standards; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards*
chemical_list: D059451:Biosimilar Pharmaceuticals